ASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapy

The American Society for Gene and Cell Therapy (ASGCT) CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the same quarter last year, which he deemed “a really promising indication.” The post ASGCT Q1 Landscape Report Paints Positive Picture for Gene and RNA Therapy appeared first on GEN - Genetic Engineering and Biotechnology News .